Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Terminated 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Sarcoma 2Other hematologic neoplasm 2Myeloid 2Lymphoid 2

Conditions

Lymphoma 142Leukemia 111Leukemia, Myeloid, Acute 100Precursor Cell Lymphoblastic Leukemia-Lymphoma 93Lymphoma, Non-Hodgkin 91Multiple Myeloma 88Lymphoma, Large B-Cell, Diffuse 80Myelodysplastic Syndromes 74Lymphoma, Follicular 73Lymphoma, Mantle-Cell 72Leukemia, Lymphocytic, Chronic, B-Cell 69Burkitt Lymphoma 67Hodgkin Disease 66Lymphoma, Large-Cell, Immunoblastic 60Lymphoma, B-Cell, Marginal Zone 49Breast Neoplasms 48Neoplasms, Plasma Cell 39Leukemia, Myeloid, Accelerated Phase 34Leukemia, Myeloid, Chronic-Phase 33Recurrence 32Myeloproliferative Disorders 32Ovarian Neoplasms 31Congenital Abnormalities 30Blast Crisis 30Sarcoma 28Dendritic Cell Sarcoma, Interdigitating 28Central Nervous System Neoplasms 28Leukemia, Myelomonocytic, Chronic 27Neuroblastoma 25Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 21

Interventions

Cytarabine 5Cyclophosphamide 3thymoglobulin 2fludarabine phosphate 2fludarabine 2devimistat 2Thiotepa 2Tacrolimus 2Rituximab 2Mitoxantrone 2Melphalan 2Granulocyte Colony-Stimulating Factor 2Filgrastim 2Cladribine 2vosaroxin 1venetoclax 1plerixafor 1pegylated granulocyte colony-stimulating factor 1blinatumomab 1aldesleukin 1Transplantation 1Stem Cell Transplantation 1Sirolimus 1Razoxane 1Mycophenolic Acid 1Metformin 1Mesna 1Interleukin-2 1Idarubicin 1Hematopoietic Stem Cell Transplantation 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Sarcoma, Myeloid × Filgrastim × Clear all
NCT02790515 2025-08-12

Provision of TCRγδ T Cells and Memory T Cells Plus Selected Use of Blinatumomab in Naïve T-cell Depleted Haploidentical Donor Hematopoietic Cell Transplantation for Hematologic Malignancies Relapsed or Refractory Despite Prior Transplantation

St. Jude Children's Research Hospital

Phase 2 Active not recruiting
170 enrolled
LymphoidMyeloidOther hematologic neoplasmSarcoma

Lymphoma, Non-Hodgkin, Myelodysplastic Syndromes, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Sarcoma, Myeloid, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Leukemia, Myelomonocytic, Juvenile

NCT02259348 2017-05-30

Repeat Transplantation for Relapsed or Refractory Hematologic Malignancies Following Prior Transplantation

St. Jude Children's Research Hospital

Phase 2 Terminated
12 enrolled 12 charts
LymphoidMyeloidOther hematologic neoplasmSarcoma

Lymphoma, Non-Hodgkin, Myelodysplastic Syndromes, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Hematologic Neoplasms, Sarcoma, Myeloid, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Leukemia, Myelomonocytic, Juvenile

Data powered by HemOnc (CC BY 4.0) Colophon âš¡